WOODSTOCK CORP - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 120 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.28 and the average weighting 1.1%.

Quarter-by-quarter ownership
WOODSTOCK CORP ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$288,000
-8.3%
4,4430.0%0.06%
-11.3%
Q3 2015$314,000
-36.4%
4,4430.0%0.07%
-23.7%
Q2 2015$494,000
+17.9%
4,4430.0%0.09%
+19.2%
Q1 2015$419,000
-15.9%
4,4430.0%0.08%
-16.1%
Q4 2014$498,000
+82.4%
4,4430.0%0.09%
+75.5%
Q3 2014$273,0004,4430.05%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
BB BIOTECH AG 2,719,998$155,502,0004.38%
Casdin Capital, LLC 295,000$16,865,0004.11%
Opaleye Management Inc. 130,000$7,432,0002.38%
Opus Point Partners Management, LLC 28,704$1,641,0001.42%
Fernwood Investment Management, LLC 27,550$1,575,0000.84%
Rhenman & Partners Asset Management AB 100,000$5,717,0000.77%
COLUMBIA WANGER ASSET MANAGEMENT LLC 760,116$43,456,0000.65%
Eventide Asset Management 214,000$12,234,0000.64%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 262,984$15,035,0000.59%
CAPITAL GUARDIAN TRUST CO 663,089$37,909,0000.54%
View complete list of AGIOS PHARMACEUTICALS INC shareholders